C-Peptide Levels in Type 1 Diabetes

Diagnostic Thresholds

The American Diabetes Association recommends C-peptide levels <200 pmol/L (<0.6 ng/mL) as consistent with type 1 diabetes, and levels <80 pmol/L (<0.24 ng/mL) as indicative of absolute insulin deficiency and severe beta cell loss 1, 2
C-peptide levels between 200-600 pmol/L (0.6-1.8 ng/mL) may indicate type 1 diabetes, MODY, or long-standing insulin-treated type 2 diabetes 1, 2

The rate of beta cell destruction in type 1 diabetes is variable, being rapid in children and slower in adults, according to the American Diabetes Association 3
In late-stage type 1 diabetes, there is little or no insulin secretion, manifested by low or undetectable plasma C-peptide levels 3

The American Diabetes Association advises against testing C-peptide within 2 weeks of a hyperglycemic emergency (DKA) 2
A random C-peptide sample within 5 hours of eating can replace formal stimulation testing for diabetes classification, as recommended by the American Diabetes Association 1, 2
For fasting C-peptide measurement, ensure simultaneous fasting plasma glucose is ≤220 mg/dL, according to the American Diabetes Association 2
If concurrent glucose is <70 mg/dL (<4 mmol/L), consider repeating the test, as recommended by the American Diabetes Association 2

Plasma glucose rather than A1C should be used to diagnose acute onset of type 1 diabetes in individuals with symptoms of hyperglycemia, according to the American Diabetes Association 3
Autoimmune markers include islet cell autoantibodies, GAD65, insulin antibodies, IA-2, IA-2b, and ZnT8, as identified by the American Diabetes Association 3
If antibody-positive, the diagnosis is type 1 diabetes regardless of C-peptide level, though C-peptide should still be low, according to the American Diabetes Association 1
Approximately 5-10% of adults with type 1 diabetes are antibody-negative, making C-peptide measurement essential in this subset, as recommended by the American Diabetes Association 1

Misdiagnosis occurs in 40% of adults with new type 1 diabetes, often misclassified as type 2 diabetes, according to the American Diabetes Association 1
C-peptide testing is only indicated in insulin-treated patients for classification purposes, as recommended by the American Diabetes Association 1
Very low C-peptide levels (<80 pmol/L) definitively indicate severe insulin deficiency and do not need repeat testing, according to the American Diabetes Association 1, 2
In insulin-treated patients, C-peptide must be measured prior to insulin discontinuation to exclude severe insulin deficiency, as recommended by the American Diabetes Association 2

A C-peptide level of 0.6 ng/mL indicates likely Type 1 diabetes or latent autoimmune diabetes in adults (LADA), requiring immediate transition to insulin therapy and further diagnostic workup with islet autoantibodies, as recommended by the American Diabetes Association 4
C-peptide <200 pmol/L (<0.6 ng/mL) is consistent with Type 1 diabetes and indicates significant beta-cell loss requiring insulin therapy, according to the American Diabetes Association 4
C-peptide 200-600 pmol/L (0.6-1.8 ng/mL) represents an indeterminate zone that may indicate Type 1 diabetes, LADA, MODY, or long-standing insulin-treated Type 2 diabetes, as stated by the American Diabetes Association 4, 5

Test for glutamic acid decarboxylase (GAD65) antibodies, islet tyrosine phosphatase 2 (IA-2) antibodies, and zinc transporter 8 (ZnT8) antibodies to confirm autoimmune etiology, as recommended by the American Diabetes Association 4, 5
If antibody-positive, the diagnosis is definitively Type 1 diabetes or LADA, and lifelong insulin therapy is required, according to the American Diabetes Association 4, 5

Initiate basal-bolus insulin regimen or consider insulin pump therapy, with multiple daily injections (MDI) with basal and mealtime insulin, and continuous glucose monitoring (CGM) is strongly recommended, as stated by the American Diabetes Association 6
Consider automated insulin delivery (AID) systems for optimal glycemic control, according to the American Diabetes Association 6

Monitor for symptoms of diabetic ketoacidosis (DKA), such as nausea, vomiting, abdominal pain, rapid breathing, and fruity breath odor, as recommended by the American Diabetes Association 4
Check urine or blood ketones during illness or when glucose >250 mg/dL, according to the American Diabetes Association 4
With C-peptide at this level, progressive beta-cell loss is likely, similar to classical Type 1 diabetes, with eventual complete insulin dependence, as stated by the American Diabetes Association 4